Sunday, June 14, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result

Intel’s Shareholder Mandate and Apple’s Limited Foundry Role: A Tale of Two Realities

Jackson Burston by Jackson Burston
May 16, 2026
in Uncategorized
0
Intel Stock
0
SHARES
15
VIEWS
Share on FacebookShare on Twitter

Intel’s annual general meeting on May 13 delivered a resounding endorsement of leadership, but the market had already moved on to assessing the real-world implications of the company’s most talked-about customer win. With 79.11 percent of voting capital represented, shareholders re-elected all 11 board nominees, approved executive compensation, and shot down activist resolutions on China risks, human rights, and the proposed permanent separation of the chair and CEO roles. The message from the owner base was clear: give management room to execute. Yet by Friday, the stock had given back more than 11 percent of its value for the week, as the scale of the Apple foundry arrangement began to sink in.

Supply-chain analyst Ming-Chi Kuo confirmed that Apple is already having Intel manufacture older, simpler processors for iPhone, iPad, and Mac using the 18A-P series with Foveros packaging. The partnership is no longer a rumor, but its scope is far narrower than the market had hoped. TSMC is still expected to cover more than 90 percent of Apple’s chip needs, and Intel’s initial yield target for 2027 sits at just 50 to 60 percent or higher. Even a clean ramp would not pry Apple away from its dominant supplier anytime soon. That dose of reality sent Intel shares to a close of €93.71 on Friday, down 5.75 percent on the day and 11.54 percent for the week.

The pullback came after a breathtaking run. The stock had touched a 52-week high of €109.88 on May 11, and despite the retreat still stands 178.86 percent higher since the start of the year. That kind of rally attracted a heavy short-seller presence, and the correction amplified their pain — but also their stubbornness. According to S3 Partners, bearish bets have generated book losses of more than $12 billion, yet the short interest as a percentage of free float remains near a yearly peak. The dynamic creates a self-reinforcing loop: any dip is worsened by shorts who are already underwater and cannot easily cover. Friday’s selloff was further fueled by a broad rotation out of semiconductor names ahead of Nvidia’s quarterly report.

Should investors sell immediately? Or is it worth buying Intel?

Fundamentally, Intel’s recent results offer real reasons for optimism. First-quarter revenue reached $13.577 billion, beating the midpoint of guidance by $1.4 billion and surpassing analyst expectations by 9.22 percent. Adjusted earnings per share came in at $0.29, well above the break-even forecast the company had issued. The data-center and AI segment grew 22 percent year over year, while Intel Foundry notched a 16 percent revenue increase. CFO David Zinsner told investors that yields on the advanced 18A process are running ahead of internal plans, and the target originally set for year-end may be achievable by mid-2026.

Yet the foundry business remains a drag. It posted an operating loss of $2.4 billion in the first quarter, a burden that the rest of the company must carry and a reminder that profitability in chip manufacturing is still years away. Analysts have taken note of the progress even as they recalibrate. Mizuho raised its price target to $124 on May 12, and Deutsche Bank lifted its target to $100 on the same day, citing the structural improvement in yields.

For Intel, the Apple contract is a marquee endorsement of its foundry strategy. It signals that the company is regaining credibility in external manufacturing, and it gives customers beyond Apple more reason to consider Intel as a second source. But the concrete test lies ahead: the ramp-up of Apple production next year. Intel must deliver stable yields and demonstrate that Apple is willing to allocate more than marginal volume. The board’s solid shareholder mandate buys management time, but the market’s snap reaction to the limited Apple scope shows that the bar for re-rating has been set high.

Ad

Intel Stock: Buy or Sell?! New Intel Analysis from June 14 delivers the answer:

The latest Intel figures speak for themselves: Urgent action needed for Intel investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 14.

Intel: Buy or sell? Read more here...

Tags: Intel
Jackson Burston

Jackson Burston

Related Posts

Novo Nordisk Stock
Analysis

Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape

June 14, 2026
BMW Stock
Automotive & E-Mobility

BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans

June 14, 2026
Uranium Energy Stock
Analysis

Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

June 14, 2026
Next Post
Marvell Technology Stock

Marvell's Optical Ambition and Insider Moves Create a Tale of Two Narratives

Ocugen Stock

Ocugen’s Gene Therapy Candidates Race Toward FDA Filings, But the Market Isn’t Ready to Celebrate

Green Bridge Metals Stock

Green Bridge Metals Faces Twin Catalysts in Minnesota After Compliance Cleanup

Recommended

Novo Nordisk Stock

Novo Nordisk Bets on Oral Wegovy to Expand Weight-Loss Market Reach

5 months ago
Blackrock Stock

BlackRock’s Global Strategy: Dividend Payouts and Market Expansion

9 months ago
D-Wave Quantum Stock

D-Wave Quantum: A Story of High Ambition Amidst Financial Crosscurrents

3 months ago
Ooma Stock

Ooma Stock: A Clash Between Analyst Optimism and Insider Selling

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Ocugen Faces a Moment of Truth as Clinical Catalysts Collide With a 55% Plunge

Amazon’s Freight Gambit and Regulatory Headwinds Eclipse Prime Day Hype

OHB’s Record Backlog and a Shifting Shareholder Base Set the Stage for a Defining Summer

Germany’s Communities Feel the Squeeze as Labour Shortage Forecast Worsens by 1.3 Million

European Lithium Faces a Trio of Hurdles as Lithium Markets Show Signs of Turning

OHB’s Free Float Squeeze Nears a Release as KKR Exit and Rocket Flight Converge

Trending

Novo Nordisk Stock
Analysis

Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape

by Rodolfo Hanigan
June 14, 2026
0

The Danish pharmaceutical heavyweight arrived at the American Diabetes Association congress in New Orleans armed with a...

BMW Stock

BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans

June 14, 2026
Uranium Energy Stock

Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

June 14, 2026
Ocugen Stock

Ocugen Faces a Moment of Truth as Clinical Catalysts Collide With a 55% Plunge

June 14, 2026
Amazon Stock

Amazon’s Freight Gambit and Regulatory Headwinds Eclipse Prime Day Hype

June 14, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape
  • BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans
  • Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com